GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PainReform Ltd (NAS:PRFX) » Definitions » Additional Paid-In Capital

PainReform (PainReform) Additional Paid-In Capital : $49.06 Mil(As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PainReform Additional Paid-In Capital?


PainReform's quarterly additional paid-in capital increased from Sep. 2023 ($45.48 Mil) to Dec. 2023 ($48.96 Mil) and increased from Dec. 2023 ($48.96 Mil) to Mar. 2024 ($49.06 Mil).

PainReform's annual additional paid-in capital increased from Dec. 2021 ($41.72 Mil) to Dec. 2022 ($43.45 Mil) and increased from Dec. 2022 ($43.45 Mil) to Dec. 2023 ($48.96 Mil).


PainReform Additional Paid-In Capital Historical Data

The historical data trend for PainReform's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PainReform Additional Paid-In Capital Chart

PainReform Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 0.18 33.02 41.72 43.45 48.96

PainReform Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.63 43.89 45.48 48.96 49.06

PainReform Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

PainReform Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of PainReform's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


PainReform (PainReform) Business Description

Traded in Other Exchanges
N/A
Address
65 Yigal Alon Street, Tel Aviv, ISR, 6744316
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.